newsfilter
← Latest News
PR Newswire·

Kazia Therapeutics Announces $2.0 Million Registered Direct Offering

Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today announced that it has...